Schedule 13G ownership disclosure
VISTAGEN THERAPEUTICS INC
Security class unavailable · CUSIP: 92840H202
Event date: 2016-05-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-16-007153
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- May 19, 2016
- Reporting period
- May 11, 2016
- Description
- Schedule 13G beneficial ownership